Over the past 12 months, 0 insiders at VYNE Therapeutics Inc. filed 0 open-market SEC Form 4 transactions on VYNE: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 15, 25 | Patrick G LeporeDirector | BUY | 15.0K | $2.92 | $44K |
| Nov 15, 23 | Patrick G LeporeDirector | BUY | 13.0K | $3.91 | $51K |
| Mar 20, 23 | Mutya HarschChief Legal Officer and GC | BUY | 10.0K | $2.50 | $25K |
| Mar 20, 23 | Patrick G LeporeDirector | BUY | 20.0K | $2.48 | $50K |
| Nov 30, 21 | Patrick G LeporeDirector | BUY | 12.5K | $1.02 | $13K |
| Aug 25, 21 | Patrick G LeporeDirector | BUY | 12.5K | $1.60 | $20K |
| Aug 16, 21 | Joseph EdelmanTenPercentOwner | SELL | 250.0K | $1.74 | $435K |
| Aug 13, 21 | Perceptive Advisors LlcTenPercentOwner | SELL | 250.0K | $1.84 | $460K |
| Aug 12, 21 | Perceptive Life Sciences Master Fund LtdTenPercentOwner | SELL | 338.9K | $2.23 | $756K |
Over the past 12 months, insiders at VYNE Therapeutics Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on VYNE, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market VYNE insider purchase in our data was $51K by Patrick G Lepore, Director, filed on Nov 15, 23.
0 different insiders at VYNE Therapeutics Inc. filed open-market SEC Form 4 transactions on VYNE over the last 12 months.
InsiderTape plots every VYNE insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every VYNE Therapeutics Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →